Answers are grounded in this paper and cite their sources.
Epidemiologic and experimental evidence suggests that blue light-blocking lenses could theoretically benefit patients with age-related macular degeneration. Clinical trials are needed to determine the effect of yellow lenses in preventing the progression of age-related macular degeneration.
No takes yet. Share an insight, caveat, or question.
Glazer-Hockstein et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: